Cargando…
Two Cases of Methimazole-Induced Agranulocytosis With Their Risk Factors
BACKGROUND: Antithyroid drugs, such as methimazole (MMI), are standard therapies for the medical management of thyrotoxicosis. Agranulocytosis is a rare but lethal adverse effect of antithyroid medications. We have reported 2 cases of MMI-induced agranulocytosis with similar risk factors that likely...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association of Clinical Endocrinology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984507/ https://www.ncbi.nlm.nih.gov/pubmed/35415227 http://dx.doi.org/10.1016/j.aace.2021.10.005 |